MariMed Inc. (MRMD) Reports In-Line Q4 EPS; Offers Guidance

MariMed Inc. (OTC: MRMD) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $35.83 million versus the consensus estimate of $35.1 million.

GUIDANCE:

MariMed Inc. sees FY2023 revenue of $150+ million, versus the consensus of $152.8 million.

For earnings history and earnings-related data on MariMed Inc. (MRMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15